kennzo

CDNA (CareDx, Inc.) - Bullish end to the Quarter

kennzo 업데이트됨   
NASDAQ:CDNA   CareDx, Inc.
CDNA

CareDx, Inc. is a commercial stage company. It develops, markets, and delivers a diagnostic surveillance solution for heart transplant recipients. The Company provides AlloMap, a noninvasive blood test used to aid in the identification of heart transplant recipients. It is also pursuing other areas of transplant surveillance, such as the use of cell-free DNA (cfDNA) as a biomarker for rejection. CareDx, Inc. is based in Brisbane, California.

Analysis/Commentary
Strong EPS and Sales Growth Y-on-Y

Based on the study of the previous quarterly earnings reports and subsequent price moves:
- Shaky start to the first half of the quarter
- Room for a return to at least the LOW point
- Trailing stop-loss on price above LOW point

GOOD LUCK.
DO YOUR OWN RESEARCH!
코멘트:
TRADE UPDATE: Successful
Exit trade for profits prior to earnings call
면책사항

이 정보와 게시물은 TradingView에서 제공하거나 보증하는 금융, 투자, 거래 또는 기타 유형의 조언이나 권고 사항을 의미하거나 구성하지 않습니다. 자세한 내용은 이용 약관을 참고하세요.